Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel So

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Plos One|January 22, 2025
Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis BMehlika Toy, David Hutton, Erin E Conners, et al.
Biomarker Insights|July 7, 2009
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular CarcinomaHongbo Sun, Mei-Sze Chua, Dorothy Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2021
Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United StatesMehlika Toy, David Hutton, Aaron M Harris, et al.
Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. CHI Conference|July 5, 2022
Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric DrugsEunkyung Jo, Myeonghan Ryu, Georgia Kenderova, et al.
British Journal of Pharmacology|July 22, 2025
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin-TGFβ signallingMingdian Tan, Wei Ye, Yi Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Clarification of PSA methods and corrected CEAC for universal HDV testing among adults with chronic HBVMehlika Toy, David Hutton, Eyasu Teshale, et al.
JAMA Network Open|November 11, 2020
Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016Michael H Le, Yee Hui Yeo, Samuel So, et al.
RSC Medicinal Chemistry|February 28, 2022
NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibodyHui Shi, Lakshmi Vageesh Huttad, Mingdian Tan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 20, 2026
The Cost-Effectiveness of Universal Hepatitis B Screening in VietnamThomas Pereira Horta, Hang Pham, Minh Nguyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2025
Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United StatesMehlika Toy, David Hutton, Eyasu Teshale, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Plos One|January 22, 2025
Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis BMehlika Toy, David Hutton, Erin E Conners, et al.
Biomarker Insights|July 7, 2009
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular CarcinomaHongbo Sun, Mei-Sze Chua, Dorothy Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2021
Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United StatesMehlika Toy, David Hutton, Aaron M Harris, et al.
Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. CHI Conference|July 5, 2022
Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric DrugsEunkyung Jo, Myeonghan Ryu, Georgia Kenderova, et al.
British Journal of Pharmacology|July 22, 2025
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin-TGFβ signallingMingdian Tan, Wei Ye, Yi Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Clarification of PSA methods and corrected CEAC for universal HDV testing among adults with chronic HBVMehlika Toy, David Hutton, Eyasu Teshale, et al.
JAMA Network Open|November 11, 2020
Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016Michael H Le, Yee Hui Yeo, Samuel So, et al.
RSC Medicinal Chemistry|February 28, 2022
NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibodyHui Shi, Lakshmi Vageesh Huttad, Mingdian Tan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 20, 2026
The Cost-Effectiveness of Universal Hepatitis B Screening in VietnamThomas Pereira Horta, Hang Pham, Minh Nguyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2025
Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United StatesMehlika Toy, David Hutton, Eyasu Teshale, et al.
Pageof 8